Cian Michael Scannell1, Amedeo Chiribiri1, Adriana Villa1, Marcel Breeuwer2,3, and Jack Lee1
1Biomedical Engineering and Imaging Sciences, King's College London, London, United Kingdom, 2Philips Healthcare, Best, Netherlands, 3Biomedical Engineering, Eindhoven University of Technology, Eindhoven, Netherlands
Synopsis
Myocardial
perfusion can be quantified from dynamic contrast-enhanced MRI. This
facilitates a non-invasive, automated, fast and user-independent evaluation of
myocardial blood flow. However, due to the relatively low SNR, low temporal
resolution and short scanning time the model fitting can yield unreliable
parameter estimates. To counter-act this, simplified models and segmental
averaging are used. In this work, Bayesian inference is employed. The inclusion
of both spatial prior knowledge and prior knowledge of the kinetic parameters
improves the reliability of the parameter estimation. This allows the
generation of accurate high-resolution voxel-wise quantitative perfusion maps
that clearly delineate areas of ischaemia.
Introduction
Dynamic
contrast-enhanced magnetic resonance imaging (DCE-MRI) can be used for the
non-invasive assessment of myocardial perfusion. Currently, the clinical
evaluation of such image series is performed visually but such an assessment is
difficult and time-consuming. Hence, the quantification of perfusion through
tracer-kinetic modelling would be desirable and would enable the clinical translation of the technique.
Quantification
is performed by fitting tracer-kinetic models to the observed imaging data in
order to estimate the model parameters. However, this model fitting is
difficult as a result of the high noise level and limited number of acquisition
points and temporal resolution, potentially leading to unreliable model
parameter estimates.1,2 To improve the robustness of the estimates, much of the
work in this field performs segment-wise averaging to improve SNR or uses
simpler but unphysiological models such as the Fermi function which leads to
the estimation of fewer physiological parameters.
However,
the averaging of signal across segments compromises the spatial information
present in the data and leads to the loss of important diagnostic information.
The use of physiologically motivated models such as the two-compartment
exchange model would also be desirable. The 2CXM model has four parameters, all
of which are physiologically interpretable (compared to one in the Fermi
function).
In this
work we propose the use of Bayesian inference to estimate the model parameters
and demonstrate the reliable fitting of the 2CXM using both simulated and patient data.Methods
Traditionally,
the parameter estimation is done using a least-squares fitting which finds the
set of parameters that minimises the least-squares between the model and the
observed data. However, such parameter estimation problems are susceptible to
convergence to local optima (Figure 1). This leads to unreliable parameter
estimates that are highly sensitive to the initial conditions of the
optimisation and the specific noise realisation present in the data.
It has
been proposed that Bayesian inference can improve the reliability of the
tracer-kinetic parameter estimation.3 Bayesian inference provides a
natural framework for the inclusion of prior knowledge of the kinetic
parameters and by using a Markov random field prior it can take advantage of
the fact that neighbouring voxels are likely to have similar kinetic
properties. A hierarchical Bayesian model is employed in this study.
Hierarchical Bayesian modelling does not use prior distributions with fixed
hyperparameters but rather with hyperparameters governed by another
distribution, a hyperprior. That is, rather than having $$$F_b \sim \mathcal{N}(\mu,\sigma^2)$$$ with a fixed value of $$$\mu$$$ instead $$$\mu$$$ is governed by a hyperprior. This choice is natural for myocardial perfusion
quantification as it is difficult to specify hyperparameters without first
knowing if a patient is healthy or diseased.
The posterior
distribution for the parameters is given through the application of Bayes’
theorem. The posterior distribution is not analytically
tractable and must be approximated using Markov chain Monte Carlo (MCMC) techniques. This Markov chain is
constructed using the Metropolis-Hastings algorithm.
The proposed method was
first tested using simulated image series as this is the only situation where
estimates can be compared to ground-truth values. The error of proposed
parameter estimation method is compared in a Monte-Carlo study for distinct noise
realisations to the least-squares fitting. The technique was subsequently
tested in eight patients suspected of having coronary artery disease. We test
whether the kinetic parameter values that are estimated can identify perfusion
defects that match the visual assessment found in the clinical reports.Results
The
average (standard deviation) mean square error with the ground-truth values for the 25 distinct noise
realisations is 4.05
(1.13) This error falls to 1.32 (0.37) when the fitting is repeated with 5
different random initial conditions. The described Bayesian inference method
reduces the error significantly to 0.078 (0.029) (Figure 2).
A
comparison of the best fit with 100 random initialisations of least-squares
fitting and the Bayesian inference for an example patient is shown in Figure 3.
The assessment of the patients’ health based purely on the quantitative flow
maps obtained using Bayesian inference matches the visual assessment in all 24
slices. When using the maps obtained by the least-squares fitting, a
corresponding assessment is only achieved in 16/24 slices (Figure 4).Conclusion
Hierarchical
Bayesian inference allows the reliable voxel-wise quantification of the kinetic
parameters of the 2CXM from myocardial perfusion MRI data. The high resolution
perfusion maps can aid the diagnosis of myocardial ischaemia. The method
however needs to be validated more thoroughly in comparison with established
techniques such as PET or microspheres. Additionally, the Bayesian framework
also allows the quantification of uncertainty which may prove beneficial in the
clinic.Acknowledgements
The authors acknowledge
financial support from the King’s College London & Imperial College London
EPSRC Centre for Doctoral Training in Medical Imaging (EP/L015226/1); Philips
Healthcare; The Department of Health via the National Institute for Health
Research (NIHR) comprehensive Biomedical Research Centre award to Guy’s &
St Thomas’ NHS Foundation Trust in partnership with King’s College London and
King’s College Hospital NHS Foundation Trust; The Centre of Excellence in Medical
Engineering funded by the Wellcome Trust and EPSRC under grant number WT
088641/Z/09/Z.
References
1. Buckley DL. Uncertainty in the analysis of tracer kinetics using dynamic contrast-enhanced T1-weighted MRI. Magn. Reson. Med. 2002;47:601–606. doi: 10.1002/mrm.10080.
2. Schwab F, Ingrisch M, Marcus R, Bamberg F, Hildebrandt K, Adrion C, Gliemi C, Nikolaou K, Reiser M, Theisen D. Tracer kinetic modeling in myocardial perfusion quantification using MRI. Magn. Reson. Med. 2015;73:1206–1215. doi: 10.1002/mrm.25212.
3. Dikaios N, Atkinson D, Tudisca C, Purpura P, Forster M, Ahmed H, Beale T, Emberton M, Punwani S. A comparison of Bayesian and non-linear regression methods for robust estimation of pharmacokinetics in DCE-MRI and how it affects cancer diagnosis. Comput. Med. Imaging Graph. 2017;56:1–10. doi: 10.1016/j.compmedimag.2017.01.003.